Gastric mucosal plasminogen activators in Helicobacter pylori infection

Digestive Diseases and Sciences

Volumn 41, Issue 8, 1996, Pages 1577-1582

  Götz, Jan Mark ^a   Vergouwe, Yvonne ^a   Verspaget, Hein W ^a   Biemond, Izäk ^a   Sier, Cornelis F M ^a   Lamers, Cornelis B H W ^a   Veenendaal, Roelof A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Gastric mucosa; Gastritis; Helicobacter pylori; Plasminogen activators

Indexed keywords

PLASMINOGEN ACTIVATOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BIOPSY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRITIS; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH MUCOSA;

EID: 0029793311     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02087903     Document Type: Article

References (30)

1. Warren JR, Marshall BJ: Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1:1273-1275, 1983
2. Blaser MJ: Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 102:720-727, 1992
3. Taylor DN, Blaser MJ: The epidemiology of Helicobacter pylori infection. Epidemiol Rev 13:42-59, 1991
4. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease: Helicobacter pylori in peptic ulcer disease. JAMA 272:65-69, 1994
5. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD: Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330:1267-1271, 1994
6. Correa P: Human gastric carcinogenesis: A multistep and multifactorial process. Cancer Res 52:6735-6740, 1992
7. Danø K, Adreasen PA, Grøndahl-Hansen J, Kristensen P, Nielsen LS, Skriver L: Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 44:139-266, 1985
8. Markus G: The relevance of plasminogen activators to neoplastic growth - a review of recent literature. Enzyme 40:158-172, 1988
9. de Bruin PAF, Crama-Bohbouth C, Verspaget HW, Verheijen JH, Dooijewaard G, Weterman IT, Lamers CBHW: Plasminogen activators in the intestine of patients with inflammatory bowel disease. Thromb Haemost 60:262-266, 1988
10. Wodziński MA, Bardhan KD, Reilly JT, Cooper P, Preston FE: Reduced tissue-type plasminogen activator activity of gastroduodenal mucosa in peptic ulcer disease. Gut 34:1310-1314, 1993
11. Kurose I, Miura S, Suematsu M, Asako H, Serizawa H, Ogata H, Hibi T, Tsuchiya M: Possible involvement of tissue-type plasminogen activator in gastric ulcer formation - biochemical evaluation using biopsy specimens from gastric mucosa. Dig Endosc 2:49-53, 1990
12. Price AB: The Sydney system: Histological division. J Gastroenterol Hepatol 6:209-222, 1991
13. Veenendaal RA, Lichtendahl-Bernards AT, Peña AS, Endtz HPh, van Boven CPA, Lamers CBHW: Effect of transport medium and transportation time on culture of Helicobacter pylori from gastric biopsy specimens. J Clin Pathol 46:561-563, 1993
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurements with the Folin phenol reagent. J Biol Chem 193:265-275, 1951
15. Binnema DJ, van Iersel JJL, Dooijewaard G: Quantitation of urokinase antigen in plasma and cultured media by use of an ELISA. Thromb Res 43:569-577, 1986
16. Rijken DC, van Hinsbergh VWM, Sens EHC: Quantitation of tissue-type plasminogen activator in human endothelial cell cultures by use of an enzyme immunoassay. Thromb Res 33:145-153, 1984
17. Verheijen JH, Mullaart E, Chang GTG, Kluft C, Wijngaards G: A simple sensitive spectrophotometric assay for extrinsic (tissue type) plasminogen activator applicable to measurements in plasma. Thromb Haemost 48:266-269, 1982
18. Raschke M, Lierse W, van Ackeren H: Microvascular architecture of the mucosa of the gastric corpus in man. Acta Anat 130:185-190, 1987
19. Raschke M: Microangioarchitecture of gastric mucosa in man: Antrum ventriculi. Acta Anat 137:175-179, 1990
20. Dooijewaard G, van Iersel JJL, Brommer EJP: Quantitation of pro-UK and UK-inhibitor levels in plasma of patients and healthy men. Fibrinolysis 1(suppl 1):142, 1986
21. Granelli-Piperno A, Reich E: A study of proteases and protease inhibitor complexes in biological fluids. J Exp Med 148:223-234, 1978
22. Sier CFM, Verspaget HW, Griffioen G, Verheijen JH, Quax PHA, Dooijewaard G, de Bruin PAF, Lamers CBHW: Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implication of urokinase in colorectal carcinogenesis. Gastroenterology 101:1522-1528, 1991
23. Stolte M, Eidt S, Ohnsmann A: Differences in Helicobacter pylori-associated gastritis in the antrum and body of the stomach. Z Gastroenterol 28:229-233, 1990
24. Opdenakker G, van Damme J: Cytokines and proteases in invasive processes: Molecular similarities between inflammation and cancer. Cytokine 4:251-258, 1992
25. Waltz DA, Sailor LZ, Chapman HA: Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activators. J Clin Invest 91:1541-1552, 1993
26. 2ft. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI: Mucosal tumour necrosis factor α and interleukin-6 in patients with Helicobarter pylori-associated gastritis. Gut 32:1473-1477, 1991
27. Crabtree JE, Pcichl P, Wyatt JI, Stachl U, Lindley IJD: Gastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection. Scand J Immunol 37:65-67, 1993
28. Møller H, Heseltine E, Vaiano H: Working group report on schistosomes, liver flukes and Helicobacter pylori. Int J Cancer 60:587-589, 1995
29. Sier CFM, Verspaget HW, Griffioen G, Ganesh S, Vloedgraven HJM, Lamers CBHW: Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach. Gut 34:80-85, 1993
30. Ganesh S, Sier CFM, Heerding MM, van Krieken JHJM, Griffioen G, Welvaart K, van de Velde CJH, Verheijen JH, Lamers CBHW, Verspaget HW: Prognostic value of the plasminogen activation system in patients with gastric cancer. Cancer 77:1035-1043, 1996